Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Methamphetamine enhances HIV infection of macrophages.

Liang H, Wang X, Chen H, Song L, Ye L, Wang SH, Wang YJ, Zhou L, Ho WZ.

Am J Pathol. 2008 Jun;172(6):1617-24. doi: 10.2353/ajpath.2008.070971. Epub 2008 May 5.

2.

Methamphetamine inhibits antigen processing, presentation, and phagocytosis.

Tallóczy Z, Martinez J, Joset D, Ray Y, Gácser A, Toussi S, Mizushima N, Nosanchuk JD, Goldstein H, Loike J, Sulzer D, Santambrogio L.

PLoS Pathog. 2008 Feb 8;4(2):e28. doi: 10.1371/journal.ppat.0040028. Erratum in: PLoS Pathog. 2008 Mar;4(3). doi: 10.1371/annotation/bd02ad26-a081-4c61-88c2-ebda285b8bca. Nosanchuk, Josh [corrected to Nosanchuk, Joshua D].

3.

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

Williams SA, Kwon H, Chen LF, Greene WC.

J Virol. 2007 Jun;81(11):6043-56. Epub 2007 Mar 21.

4.

Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance.

Colfax GN, Vittinghoff E, Grant R, Lum P, Spotts G, Hecht FM.

AIDS. 2007 Jan 11;21(2):239-41.

PMID:
17197817
6.

Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I; HIV Neurobehavioral Research Center Group.

J Infect Dis. 2003 Dec 15;188(12):1820-6. Epub 2003 Dec 8.

PMID:
14673760
7.

Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas.

Thiede H, Valleroy LA, MacKellar DA, Celentano DD, Ford WL, Hagan H, Koblin BA, LaLota M, McFarland W, Shehan DA, Torian LV; Young Men's Survey Study Group.

Am J Public Health. 2003 Nov;93(11):1915-21.

8.

Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis.

Varin A, Manna SK, Quivy V, Decrion AZ, Van Lint C, Herbein G, Aggarwal BB.

J Biol Chem. 2003 Jan 24;278(4):2219-27. Epub 2002 Nov 4.

9.

Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice.

Yu Q, Zhang D, Walston M, Zhang J, Liu Y, Watson RR.

Int Immunopharmacol. 2002 Jun;2(7):951-62.

PMID:
12188036
10.

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC.

Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905.

12.

Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells.

Lee YW, Hennig B, Yao J, Toborek M.

J Neurosci Res. 2001 Nov 15;66(4):583-91.

PMID:
11746378
13.

Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Hiscott J, Kwon H, Génin P.

J Clin Invest. 2001 Jan;107(2):143-51. Review. No abstract available.

14.

Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: a new in vivo system for studying the postintegration phase of HIV replication.

Browning Paul J, Wang EJ, Pettoello-Mantovani M, Raker C, Yurasov S, Goldstein MM, Horner JW, Chan J, Goldstein H.

AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):481-92.

PMID:
10772534
15.

Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.

Muñoz-Fernández MA, Navarro J, Garcia A, Punzón C, Fernández-Cruz E, Fresno M.

J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):838-45.

PMID:
9438495
16.

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection.

Browning J, Horner JW, Pettoello-Mantovani M, Raker C, Yurasov S, DePinho RA, Goldstein H.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14637-41.

Supplemental Content

Support Center